Global /Australia /Healthcare /Medical Devices /EMV

EMVision Medical Devices Ltd.

EMV

• ASX: EMV • Delayed

1.78AUD 0.6%

1.27 USD

As of 5 June 2026, EMVision Medical Devices Ltd. has a market cap of $117.39M USD, ranking #24456 globally and #553 in Australia. It ranks #2187 in the Healthcare sector, and #452 in the Medical Devices industry.

Global Rank

24456

Country Rank

553

Sector Rank

2187

Industry Rank

452

Key Stats

Market Cap

$117.39MUSD

164.5M AUD

Enterprise Value

$107.36MUSD

150.44M AUD

Revenue (TTM)

$3.87MUSD

5.43M AUD

EBITDA (TTM)

-$6.71MUSD

-9.4M AUD

Net Income (TTM)

-$7.28MUSD

-10.2M AUD

EBITDA Margin

-173%

Profit Margin

-188%

PS Ratio

30.3

PB Ratio

8.3

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Devices

CEO

Scott Kirkland open_in_new

Founded

2017

Website

emvision.com.au open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.6%	-1.4%	14%	-1.8%	-4.3%	-0.6%	-9.7%	13%	-44%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	EMV EMvision Medical Devices Ltd Ordinary Shares ISIN: AU0000028375 Shares Out.: Shares Outstanding: 92.956M¹ Shares Float: 60.092M² TV: TradingView: ASX: EMV SA: Stock Analysis: ASX: EMV YF: Yahoo Finance: EMV.AX GF: Google Finance: ASX: EMV BA: Barron's: EMV MS: Morningstar: XASX: EMV	1.78 AUD	TV: TradingView: ASX: EMV SA: Stock Analysis: ASX: EMV YF: Yahoo Finance: EMV.AX GF: Google Finance: ASX: EMV BA: Barron's: EMV MS: Morningstar: XASX: EMV

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About EMVision Medical Devices Ltd.

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

Similar Companies

Industry: Medical Devices (Australia)

Name	Market Cap (USD) diff.	PE	Country
Cochlear Ltd. ASX: COH	$4.2B 5.89B AUD 3K%	17.1	Australia
EBOS Group Ltd. NZE: EBO	$2.55B 4.34B NZD 2K%	16.0	Australia
Clarity Pharmaceuticals Ltd. ASX: CU6	$786.34M 1.1B AUD 570%	-	Australia
Nanosonics Ltd. ASX: NAN	$743.12M 1.04B AUD 533%	52.3	Australia
Tetratherix Ltd. ASX: TTX	$171.0M 239.61M AUD 46%	-	Australia
Orthocell Ltd. ASX: OCC	$170.38M 238.75M AUD 45%	-	Australia

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 147K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 137K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 135K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 108K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 103K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 87K%	22.2	Ireland

chevron_leftBack